Advertisement
Advertisement
PODD
Insulet Corporation
175.04
USDSponsored
+2.90
+1.68%
May 01, 16:00 UTC -4
Closed
After-Market
175.03
-0.01
-0.01%
PODD Earnings Reports
Positive Surprise Ratio
PODD beat 28 of 41 last estimates.
68%
Next Report
In 3 Days
Date of Next Report
May 06, 2026
Estimate for Q1 26 (Revenue/ EPS)
$742.92M
/$1.22
Implied change from Q4 25 (Revenue/ EPS)
-5.22%
/-21.29%
Implied change from Q1 25 (Revenue/ EPS)
+30.57%
/+20.79%
Insulet Corporation earnings per share and revenue
On Feb 18, 2026, PODD reported earnings of 1.55 USD per share (EPS) for Q4 25, beating the estimate of 1.48 USD, resulting in a 4.50% surprise. Revenue reached 783.80 million, compared to an expected 784.07 million, with a -0.03% difference. The market reacted with a +4.76% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 24 analysts forecast an EPS of 1.22 USD, with revenue projected to reach 742.92 million USD, implying an decrease of -21.29% EPS, and decrease of -5.22% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Stryker Corporation
Report Date
Apr 30, 2026 For Q1 26
Estimate
$3.01
Actual
$2.60
Surprise
-13.75%
Boston Scientific Corp.
Report Date
Apr 22, 2026 For Q1 26
Estimate
$0.79
Actual
$0.80
Surprise
+0.69%
GE HealthCare Technologies Inc. Common Stock
Report Date
Apr 29, 2026 For Q1 26
Estimate
$1.07
Actual
$0.99
Surprise
-7.55%
ResMed Inc.
Report Date
Apr 30, 2026 For Q3 26
Estimate
$2.82
Actual
$2.86
Surprise
+1.20%
Zimmer Biomet Holdings, Inc.
Report Date
Apr 28, 2026 For Q1 26
Estimate
$1.88
Actual
$2.09
Surprise
+10.99%
Baxter International Inc.
Report Date
Apr 30, 2026 For Q1 26
Estimate
$0.31
Actual
$0.36
Surprise
+15.72%
Bio-Rad Laboratories, Inc.Class A
Report Date
Apr 30, 2026 For Q1 26
Estimate
$2.00
Actual
$1.89
Surprise
-5.68%
Cerus Corp
Report Date
Apr 30, 2026 For Q1 26
Estimate
-$0.04
Actual
-$0.01
Surprise
+75.49%
FAQ
What were Insulet Corporation's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Insulet Corporation reported EPS of $1.55, beating estimates by 4.5%, and revenue of $783.80M, -0.03% below expectations.
How did the market react to Insulet Corporation's Q4 2025 earnings?
The stock price moved up 4.76%, changed from $246.34 before the earnings release to $258.07 the day after.
When is Insulet Corporation expected to report next?
The next earning report is scheduled for May 06, 2026.
What are the forecasts for Insulet Corporation's next earnings report?
Based on 24
analysts, Insulet Corporation is expected to report EPS of $1.22 and revenue of $742.92M for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement